Onyedika Emmanuel Okpala

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Anti Inflammatory Drugs

Candida Albicans

Methicillin Resistant Staphylococcus Aureus

Cystic Fibrosis

Top Venues

Nature biotechnology

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Onyedika Emmanuel Okpala, Johana Rondevaldova, Hayford Osei-Owusu, Tomas Kudera, Tersia Kokoskova, Ladislav Kokoska
Susceptibility of Staphylococcus aureus to Anti-Inflammatory Drugs with a Focus on the Combinatory Effect of Celecoxib with Oxacillin In Vitro. Molecules (Basel, Switzerland) 29 (15) (2024)
Onyedika Emmanuel Okpala, Johana Rondevaldova, Hayford Osei-Owusu, Tomas Kudera, Tersia Kokoskova, Ladislav Kokoska
Susceptibility of Staphylococcus aureus to Anti-Inflammatory Drugs with a Focus on the Combinatory Effect of Celecoxib with Oxacillin In Vitro. Molecules (Basel, Switzerland) 29 (15) (2024)
Almut Heinken, Johannes Hertel, Geeta Acharya, Dmitry A Ravcheev, Malgorzata Nyga, Onyedika Emmanuel Okpala, Marcus Hogan, Stefanía Magnúsdóttir, Filippo Martinelli, Bram Nap, German Andres Preciat Gonzalez, Janaka N Edirisinghe, Christopher S Henry, Ronan M T Fleming, Ines Thiele
Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine. Nature biotechnology (2023)
Almut Heinken, Johannes Hertel, Geeta Acharya, Dmitry A Ravcheev, Malgorzata Nyga, Onyedika Emmanuel Okpala, Marcus Hogan, Stefanía Magnúsdóttir, Filippo Martinelli, Bram Nap, German Andres Preciat Gonzalez, Janaka N Edirisinghe, Christopher S Henry, Ronan M T Fleming, Ines Thiele
Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine. Nature biotechnology (2023)